To Evaluate the Effect of Food on the Pharmacokinetics (PK) of AZD0328
Status and phase
Completed
Phase 1
Conditions
Healthy
Treatments
Drug: AZD0328
Study type
Interventional
Funder types
Industry
Identifiers
Details and patient eligibility
About
The purpose of the study is to evaluate the effect of food on the pharmacokinetics of AZD0328 in healthy male volunteers. AZD0328 will be administered as a single oral dose (capsule) during two treatment periods, after food intake or during fasting condition.
Enrollment
14 patients
Sex
Male
Ages
20 to 45 years old
Volunteers
Accepts Healthy Volunteers
Inclusion criteria
- Healthy male Caucasian subjects.
- Clinically normal physical findings, laboratory values, vital signs and resting ECG as judged by the investigator.
- Signed informed consent form
Exclusion criteria
- History of clinically significant cardio or cerebrovascular, pulmonary, renal, hepatic, neurological, mental or gastrointestinal disorder (including dyspepsia or GERD) or any other major disorder that may interfere with the study.
- Intake of another investigational drug or participation in another study which may interfere with the objectives of the study, within 12 weeks before the administration of the investigational product.
Trial design
14 participants in 2 patient groups
1
Experimental group
Description:
AZD0328 administration during fasting condition
Treatment:
Drug: AZD0328
2
Experimental group
Description:
AZD0328 administration after food intake
Treatment:
Drug: AZD0328
Trial contacts and locations
1
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems